pulmonary arterial hypertension

基本解釋

This study thoroughly examines the following markets: orphan diseases, Gaucher's Disease and Pulmonary Arterial Hypertension (PAH) markets in Europe.
該項研究通過調(diào)查以下市場：孤兒疾病，高歇病和歐洲的肺動脈高壓（PAH）市場。
AIM: To investigate changes of carbon monoxide (CO) in plasma and tissue during acute hypoxia and effect of exogenous CO on acute hypoxic pulmonary arterial hypertension.
目的：觀察急性缺氧時血漿、組織內(nèi)源性一氧化碳的變化及外源性一氧化碳對急性肺動脈高壓的影響。
Therefore, the present authors conclude that fenfluramine exposure characterises a potent trigger for pulmonary arterial hypertension without influencing its clinical course.
因此，芬氟拉明的服用僅是肺動脈高壓潛在的觸發(fā)因素，不會影響臨牀進程。

The drug is already approved to treat pulmonary arterial hypertension via other delivery methods.
FORBES: Pharma News: United Therapeutics, Zogenix, Par Pharmaceuticals
The company has tried to create new enthusiasm with with efforts to expand into hepatitis C, the viral liver disease that is looking like the next big drug market, and into other areas such as heart disease, cystic fibrosis, and pulmonary arterial hypertension.
FORBES: Gilead Tries To Revive Itself With $11 Billion Purchase Of Pharmasset
The study of a sustained release oral formulation of the synthetic form of prostacylin showed that patients treated for pulmonary arterial hypertension did not achieve a statistically significant improvement in how far they were able to walk within six minutes by week 16 of the trial.
FORBES: Pharma News: United Therapeutics, Zogenix, Par Pharmaceuticals

pulmonary y arterial hypertension 肺動脈高壓
idiopathic pulmonary arterial hypertension 特發(fā)性肺動脈高壓;動脈高壓;採用特發(fā)性肺動脈高壓;稱爲(wèi)特發(fā)性肺動脈高壓
pulmonary arterial hypertension PAH 肺動脈高壓
associated pulmonary arterial hypertension 相關(guān)性肺動脈高壓
mean pulmonary arterial hypertension 平均肺動脈壓力